Company Filing History:
Years Active: 2018
Title: Robyn L. Stanfield: Innovator in HIV Research
Introduction
Robyn L. Stanfield is a distinguished inventor based in San Diego, California, recognized for her contributions to the field of immunology. With a focus on HIV research, Stanfield has developed innovative approaches that aid in the understanding and treatment of this virus.
Latest Patents
Stanfield holds a significant patent related to her groundbreaking work titled "HIV-1 gp120 mini V3 loop and uses thereof." This invention pertains to an immunogenic HIV-1 gp120 mini V3 loop, which is a truncated version of the full-length gp120 V3 loop. It proves to be useful for crystallization with antibodies that recognize carbohydrate moieties. The patent also encompasses the structure of a broadly neutralizing antibody as a complex with a glycosylated gp120 outer domain, as determined by crystallographic techniques. Key findings include the confirmation that the glycosylated gp120 outer domain possesses a functionally relevant conformation and the identification of crucial residues on this glycosylated domain, alongside various compounds and compositions derived from these insights. Additionally, the invention highlights other peptides and mimetic peptides capable of binding to broadly neutralizing antibodies.
Career Highlights
Robyn L. Stanfield is affiliated with The Scripps Research Institute, renowned for its groundbreaking explorations in biomedical science. Her research and innovations have significantly advanced the understanding of HIV, providing valuable insights for further therapeutic developments.
Collaborations
Throughout her career, Stanfield has collaborated with renowned scientists, including Ian A. Wilson and Robert Pejchal. These collaborations reflect her commitment to fostering teamwork within the scientific community to propel advancements in HIV research.
Conclusion
Robyn L. Stanfield stands out as an influential inventor whose work in the field of HIV research is paving the way for innovative treatments. Her patent on the HIV-1 gp120 mini V3 loop exemplifies her dedication to the ongoing fight against this virus, showcasing the important intersection of science and innovation in addressing global health challenges.